Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityActive in the last 2 years

Fu‐Yu Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2755-2887; OpenAlex author ID A5084247030. Sources: OpenAlex.

Their work

Papers
7 (first author 2, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
14
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 7

  1. Toward Timely Diagnosis of Pancreatic Cancer: Revolutionizing Early Detection Through Genomics, Artificial Intelligence, and Noninvasive Biomarkers. Co-author DOI 10.1111/jgh.70281↗
  2. Comparison of the upfront surgery and neoadjuvant therapy in resectable and borderline resectable pancreatic cancer: an updated systematic review and meta-anal… Co-author DOI 10.1007/s13304-023-01626-0↗
  3. DNA damage repair mutations in pancreatic cancer- prognostic or predictive? Last author DOI 10.3389/fonc.2023.1267577↗
  4. The consistencies and inconsistencies between distal cholangiocarcinoma and pancreatic ductal adenocarcinoma: A systematic review and meta-analysis. Last author DOI 10.3389/fonc.2022.1042493↗
  5. Comment on "Outcomes of Elective and Emergency Conversion in Minimally Invasive Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma: An International Mu… Last author DOI 10.1097/sla.0000000000004283↗
  6. Predictors of Resectability and Survival in Patients with Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment with FOLFIRINOX. First author DOI 10.1097/sla.0000000000002842↗
  7. Re-evaluating the impact of tumor size on survival following pancreaticoduodenectomy for pancreatic adenocarcinoma. First author DOI 10.1002/jso.21883↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hai‐Jie Hu · 5 shared papers, 2018–2026 · strength 1.25
  2. Tian‐Run Lv · 2 shared papers, 2022–2023 · strength 0.39
  3. Ya-Fei Hu · 2 shared papers, 2022–2023 · strength 0.39
  4. Hussain Ma · 1 shared paper, 2026 · strength 0.36
  5. Siqi Yang · 1 shared paper, 2024 · strength 0.28
  6. Nan-Sheng Cheng · 1 shared paper, 2021 · strength 0.22
  7. Heng‐Chung Kung · 1 shared paper, 2023 · strength 0.22
  8. Jun Yu · 1 shared paper, 2023 · strength 0.22
  9. Joseph M. Herman · 1 shared paper, 2011 · strength 0.02
  10. Mechteld Christine De Jong · 1 shared paper, 2011 · strength 0.02
  11. Barish H. Edil · 1 shared paper, 2011 · strength 0.02
  12. Christopher Lee Wolfgang · 1 shared paper, 2011 · strength 0.02
  13. Timothy Michael Pawlik · 1 shared paper, 2011 · strength 0.02
  14. Richard David Schulick · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.